New research identifying “shared biology across ME/CFS, long COVID, PTSD, rheumatoid arthritis, and multiple sclerosis” discussed on BBC Radio 4’s Today Programme.

Research highlighting “shared biology across ME/CFS, long COVID, PTSD, rheumatoid arthritis, and multiple sclerosis” was discussed on BBC Radio 4’s Today Programme on the 3rd of September (listen at approximately 2.48.12). In the episode, Prof. Dmitri Pchejetski, who led the study, alongside colleagues including first author of the paper Dr Ewan Hunter, stated that when […]

Brain tissue changes in ME/CFS and long COVID

Researchers Tanoj Bahadur Singh, Sonya Marshall-Gradisnik, Leighton Barnden, Natalie Eaton-Fitch, Tuong Hieu Huynh, Maira Inderyas, Kiran Thapaliya Institution National Center for Neuroimmunology and Emerging Diseases (NCNED), Griffith University, Gold Coast, Queensland, Australia Publication Frontiers in Medicine – Translational Medicine, 2026 July 17; 13:1824498 Funding This research was funded by ME Research UK (SCIO Charity Number […]

ME Research UK co-funded research: muscle problems in long COVID and ME/CFS cannot be explained by prolonged inactivity

A team of researchers – including ME Research UK-funded researcher Associate Professor Rob Wüst – has published a manuscript in the leading science journal, Nature Communications, highlighting that muscle problems in long COVID and ME/CFS cannot be explained by prolonged inactivity. A recent press release emphasises the importance of their findings: “The findings are important […]

NHS Template Services for ME/CFS and long COVID

When Baroness Merron, Parliamentary Under-Secretary (Department of Heath and Social Care) divulged in her written answer of 9th June 2026 that “There are currently no plans to develop a separate specification for severe and very severe ME/CFS” it seemed an end to the possibility of a centre-created template for specialist services for those most affected […]

Orexins and GLP-1s as they relate to long COVID and ME/CFS

A recent review highlighted the devastating multi-system effects of COVID on the body, particularly emphasising the endocrinological (hormonal) consequences manifesting in long COVID, and additionally ME/CFS in a proportion of people. The review honed in on the potential influences of chemical messenger orexin and glucagon-like peptide-1 (GLP-1) “another key player in metabolism”. Why Orexin? Orexins are neuropeptides […]

Considering the prevalence of long COVID 

NB: When considering information concerning groups of people with ME/CFS and those with long COVID, it is important to remember that ME/CFS is a symptom-based clinical diagnosis not a mechanistic one. It is clear there is a high degree of shared pathophysiology between ME/CFS and long COVID, and the two diagnostic labels are not mutually […]

What are the difficulties in arriving at a consensus regarding the prevalence of long COVID? – Part 2

Key points Introduction In this, the second of two articles discussing the difficulties faced when attempting to reach a consensus regarding a prevalence estimate for long COVID (LC), ME Research UK will highlight: Awareness of LC, medical gaslighting, and avoidance of diagnosis due to stigma In the “long COVID status report”, which was published in February 2025 to summarise […]

Verified by MonsterInsights